Regenerative medicine involves repairing or replacing damaged cells and tissues within the body. Therapy can be effected by stimulating the body to repair itself or by introducing cells and/or factors which repair or replace the damaged or diseased tissues. New tissues and organs may also be grown in a laboratory and implanted into the body. An important part of regenerative medicine is the use of stem cells to treat patients directly or to form new tissues and organs. Regenerative medicine may also involve the use of other controversial techniques, such as parthenogenesis and therapeutic cloning.
Many inventions in the field of regenerative medicine are in principle patentable. However, the law surrounding the patenting of this technology, especially stem cells and therapeutic cloning, is complicated and varies in different countries around the world. J A Kemp’s Biotechnology and Life Sciences Group has considerable experience in prosecuting patent applications relating to regenerative medicine and the problems that may be faced in different countries.
We pride ourselves on finding innovative solutions to overcoming these problems and work closely with our clients to try to protect novel therapeutic methods, as well as stem cells and downstream tissues and organs as compositions of matter. We have also been involved in some high profile cases on this topic, such as representing Wisconsin Alumni Research Foundation (WARF) in the landmark case that led to the Enlarged Board of Appeal Decision G2/06 (patentability of human embryonic stem cells).